Neuronetics, Inc.
Provides non-drug, non-invasive TMS therapy for depression, OCD, and other neurohealth disorders.
STIM | US
Overview
Corporate Details
- ISIN(s):
- US64131A1051
- LEI:
- Country:
- United States of America
- Address:
- 3222 PHOENIXVILLE PIKE, 19355 MALVERN
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Neuronetics, Inc. is a commercial-stage medical technology company focused on developing and commercializing non-invasive therapies for neurohealth disorders. Its flagship product, the NeuroStar® Advanced Therapy system, is a leading transcranial magnetic stimulation (TMS) treatment. It provides a non-drug, non-invasive option for patients with psychiatric conditions, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and anxiety symptoms associated with MDD. As a market leader, the company's technology is supported by the largest clinical data set for any TMS therapy for depression and has broad insurance coverage. Neuronetics provides extensive sales and customer support to psychiatric practices and is focused on expanding its technology to additional indications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all Neuronetics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neuronetics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neuronetics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
